Search Orphan Drug Designations and Approvals
-
Generic Name: | Peldesine |
---|---|
Date Designated: | 10/05/1993 |
Orphan Designation: | Treatment of cutaneous T-cell lymphoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
BioCryst Pharmaceuticals, Inc. 2190 Parkway Lake Drive Birmingham, Alabama 35244 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-